The position of the American Academy of Clinical Toxicology (AACT), endorsed by the American College of Medical Toxicology (ACMT) is as follows: The American Academy of Clinical Toxicology supports appropriate scheduling of drugs in adherence to the scheduling guidelines specified by the Controlled Substances Act (CSA). Scheduling medications without following established best practices and existing Drug Enforcement Agency (DEA) guidelines may limit access to care and represents a threat to public safety.
Arens et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: